Clients

Arch Therapeutics, Inc.

Company Snapshot: Arch Therapeutics, Inc.

ARTH
Last Change Volume High Low

Company Overview

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Featured Documents

Client News

  1. Jun 6 2017 Arch Therapeutics Presents Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
  2. May 22 2017 Arch Therapeutics to Provide Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
  3. Mar 6 2017 Arch Therapeutics to Provide Corporate Update at the 29th Annual Roth Conference on Monday, March 13, 2017
  4. Feb 27 2017 Arch Therapeutics to Provide Corporate Update at the Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference